Telephone: 01344 424600
Email: communications.bra@boehringer-ingelheim.com
Website: https://www.carmelinatrial.com/
Contact Name: The Owner
CARMELINA® is a long-term cardiovascular outcomes trial (CVOT) testing the impact of treatment with linagliptin versus placebo, on top of standard of care, on cardiovascular as well as kidney safety.
Back to the list of companies in this category